The estimated Net Worth of Jinn Wu is at least $712 Tysiąc dollars as of 3 August 2022. Jinn Wu owns over 10,000 units of Athenex Inc stock worth over $96,957 and over the last 7 years he sold ATNX stock worth over $465,500. In addition, he makes $149,960 as Independent Director at Athenex Inc.
Jinn has made over 17 trades of the Athenex Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of ATNX stock worth $4,200 on 3 August 2022.
The largest trade he's ever made was selling 98,000 units of Athenex Inc stock on 3 March 2021 worth over $465,500. On average, Jinn trades about 14,643 units every 58 days since 2017. As of 3 August 2022 he still owns at least 484,783 units of Athenex Inc stock.
You can see the complete history of Jinn Wu stock trades at the bottom of the page.
Dr. Jinn Wu Ph.D. serves as Independent Director of the Company. Dr. Wu has served as Chief Scientific Officer and Senior Vice President of WuXi AppTec from 2015 to 2016 and, from 2017 through October 2018, as Scientific Strategic Advisor to WuXi AppTec Group. Dr. Wu has served as Chairman of the Board of AiViva Biopharma since 2016 and a member of the board of directors of Handa Biopharmaceuticals, Inc. since 2017. Dr. Wu earned a Ph.D in Natural Products and Medicinal Chemistry from Ohio State University and spent several years as a research scientist at FMC Corporation (NYSE: FMC) before founding XBL. He is an adjunct professor at the Rutgers School of Biomedical and Health Sciences and is a member of the American Association of Pharmaceutical Scientists, the International Society for the Study of Xenobiotics, the American Society of Pharmacognosy and the American Chemical Society. Wu serves as a valuable member of our Board due to his extensive medical experience and experience with clinical and preclinical research services.
As the Independent Director of Athenex Inc, the total compensation of Jinn Wu at Athenex Inc is $149,960. There are 11 executives at Athenex Inc getting paid more, with Johnson Lau having the highest compensation of $4,483,840.
Jinn Wu is 71, he's been the Independent Director of Athenex Inc since 2007. There are 3 older and 13 younger executives at Athenex Inc. The oldest executive at Athenex Inc is John Vierling, 74, who is the Independent Director.
Jinn's mailing address filed with the SEC is C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203.
Over the last 7 years, insiders at Athenex Inc have traded over $33,215,399 worth of Athenex Inc stock and bought 5,920,005 units worth $73,651,360 . The most active insiders traders include Advisors Llcperceptive Life..., Song Yi Zhang oraz Song Yi Mandra Medical Ltd .... On average, Athenex Inc executives and independent directors trade stock every 12 days with the average trade being worth of $10,843. The most recent stock trade was executed by Joe Annoni on 22 February 2023, trading 625 units of ATNX stock currently worth $125.
athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. the company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. our business includes medical technology innovation centers and a unique manufacturing supply chain across both china and north america. through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex Inc executives and other stock owners filed with the SEC include: